Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenichiro Sato

Showing results (31-40 of 107) with videos related to

Pageof 11
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthSaki Nakashima, Kenichiro Sato, Yoshiki Niimi, et al.
JAR Life|March 21, 2025
Factors affecting participation in web-based Alzheimer's questionnaire surveys: Lessons from the Japanese trial-ready cohortSaki Nakashima, Kenichiro Sato, Yoshiki Niimi, et al.
Journal of Cardiology|September 8, 2021
Stress cardiomyopathy (Takotsubo syndrome) in patients who received adrenergic agonist drugs: A pharmacovigilance study using the Japanese Adverse Drug Event Report (JADER) databaseKenichiro Sato, Atsushi Iwata, Masanori Kurihara, et al.
Frontiers in Neurology|May 20, 2022
Automated Evaluation of Conventional Clock-Drawing Test Using Deep Neural Network: Potential as a Mass Screening Tool to Detect Individuals With Cognitive DeclineKenichiro Sato, Yoshiki Niimi, Tatsuo Mano, et al.
Bioscience Trends|April 21, 2022
Time to onset of drug-induced parkinsonism: Analysis using a large Japanese adverse event self-reporting databaseKenichiro Sato, Yoshiki Niimi, Tatsuo Mano, et al.
Biomedicines|August 29, 2024
Regional Variability in MRI Scans with Different Magnetic Field Strengths in Japan: Implications for Healthcare Preparedness for Alzheimer's Disease TreatmentKenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
Journal of Alzheimer'S Disease : JAD|September 13, 2024
Adverse Events as a Cause of Unblinding of Allocated Arms in Anti-Amyloid Therapy Trials: A Meta-Analysis of the Predictive ValueKenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2026
Study partner profile effects on CDR-SB change in anti-amyloid therapy evaluationAmbre Mounié, Kenichiro Sato, Saki Nakashima, et al.
Clinical Nuclear Medicine|March 15, 2016
Reduced 123I Ioflupane Binding in Bilateral Diabetic Chorea: Findings With 18F FDG PET, 99mTc ECD SPECT, and 123I MIBG ScintigraphyKenichiro Sato, Ayumi Hida, Masashi Kameyama, et al.
Plos One|November 15, 2019
Quantifying normal and parkinsonian gait features from home movies: Practical application of a deep learning-based 2D pose estimatorKenichiro Sato, Yu Nagashima, Tatsuo Mano, et al.
Pageof 11

Showing results (31-40 of 107) with videos related to

Sort By:
Pageof 11
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthSaki Nakashima, Kenichiro Sato, Yoshiki Niimi, et al.
JAR Life|March 21, 2025
Factors affecting participation in web-based Alzheimer's questionnaire surveys: Lessons from the Japanese trial-ready cohortSaki Nakashima, Kenichiro Sato, Yoshiki Niimi, et al.
Journal of Cardiology|September 8, 2021
Stress cardiomyopathy (Takotsubo syndrome) in patients who received adrenergic agonist drugs: A pharmacovigilance study using the Japanese Adverse Drug Event Report (JADER) databaseKenichiro Sato, Atsushi Iwata, Masanori Kurihara, et al.
Frontiers in Neurology|May 20, 2022
Automated Evaluation of Conventional Clock-Drawing Test Using Deep Neural Network: Potential as a Mass Screening Tool to Detect Individuals With Cognitive DeclineKenichiro Sato, Yoshiki Niimi, Tatsuo Mano, et al.
Bioscience Trends|April 21, 2022
Time to onset of drug-induced parkinsonism: Analysis using a large Japanese adverse event self-reporting databaseKenichiro Sato, Yoshiki Niimi, Tatsuo Mano, et al.
Biomedicines|August 29, 2024
Regional Variability in MRI Scans with Different Magnetic Field Strengths in Japan: Implications for Healthcare Preparedness for Alzheimer's Disease TreatmentKenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
Journal of Alzheimer'S Disease : JAD|September 13, 2024
Adverse Events as a Cause of Unblinding of Allocated Arms in Anti-Amyloid Therapy Trials: A Meta-Analysis of the Predictive ValueKenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2026
Study partner profile effects on CDR-SB change in anti-amyloid therapy evaluationAmbre Mounié, Kenichiro Sato, Saki Nakashima, et al.
Clinical Nuclear Medicine|March 15, 2016
Reduced 123I Ioflupane Binding in Bilateral Diabetic Chorea: Findings With 18F FDG PET, 99mTc ECD SPECT, and 123I MIBG ScintigraphyKenichiro Sato, Ayumi Hida, Masashi Kameyama, et al.
Plos One|November 15, 2019
Quantifying normal and parkinsonian gait features from home movies: Practical application of a deep learning-based 2D pose estimatorKenichiro Sato, Yu Nagashima, Tatsuo Mano, et al.
Pageof 11